Market Research Logo

Neurosigma Inc - Product Pipeline Analysis, 2018 Update

Summary

Neurosigma Inc (Neurosigma) is a life science company that develops and commercializes trigeminal nerve stimulation technologies for neurologic and psychiatric disorders. The company offers treatments for epilepsy, depression, attention deficit hyperactivity disorder, and post-traumatic stress disorders. It also conducts preclinical research and development, and phase clinical trials. The company trigeminal nerve stimulation has been investigated as a therapy for epilepsy, depression, attention deficity hyperactivity disorder, and post-traumatic stress disorder, Lennox-Gastaut syndrome and traumatic brain injuries, among others. NeuroSigma is headquartered in Los Angeles, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Neurosigma Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


  • Neurosigma Inc Company Overview
    • Neurosigma Inc Company Snapshot
    • Neurosigma Inc Pipeline Products and Ongoing Clinical Trials Overview
      • Table Neurosigma Inc Pipeline Products and Ongoing Clinical Trials Overview
      • Table Neurosigma Inc Pipeline Products by Equipment Type
      • Table Figure 1: Neurosigma Inc Pipeline Products by Equipment Type
      • Table Neurosigma Inc Pipeline Products by Indication
  • Neurosigma Inc – Pipeline Analysis Overview
    • Neurosigma Inc - Key Facts
      • Table Neurosigma Inc, Key Facts
    • Neurosigma Inc - Major Products and Services
      • Table Neurosigma Inc, Major Products and Services
    • Neurosigma Inc Pipeline Products by Development Stage
      • Table Figure 2: Neurosigma Inc Pipeline Products by Development Stage
      • Table Neurosigma Inc Number of Pipeline Products by Development Stage
      • Table Neurosigma Inc Pipeline Products Summary by Development Stage
    • Neurosigma Inc Ongoing Clinical Trials by Trial Status
      • Table Figure 3: Neurosigma Inc Ongoing Clinical Trials by Trial Status
      • Table Neurosigma Inc Ongoing Clinical Trials by Trial Status
      • Table Neurosigma Inc Ongoing Clinical Trials Summary
  • Neurosigma Inc Pipeline Products Overview
    • Deep Brain Stimulation System - Cachexia
      • Deep Brain Stimulation System - Cachexia Product Overview
        • Table Deep Brain Stimulation System - Cachexia - Product Status
        • Table Deep Brain Stimulation System - Cachexia - Product Description
    • Deep Brain Stimulation System - Obesity
      • Deep Brain Stimulation System - Obesity Product Overview
        • Table Deep Brain Stimulation System - Obesity - Product Status
        • Table Deep Brain Stimulation System - Obesity - Product Description
    • Flow-Diverting TFN Stent
      • Flow-Diverting TFN Stent Product Overview
        • Table Flow-Diverting TFN Stent - Product Status
        • Table Flow-Diverting TFN Stent - Product Description
    • Micropatterned TFN Stent
      • Micropatterned TFN Stent Product Overview
        • Table Micropatterned TFN Stent - Product Status
        • Table Micropatterned TFN Stent - Product Description
    • Monarch eTNS System - ADHD
      • Monarch eTNS System - ADHD Product Overview
        • Table Monarch eTNS System - ADHD - Product Status
        • Table Monarch eTNS System - ADHD - Product Description
      • Monarch eTNS System - ADHD Clinical Trial
        • Table Monarch eTNS System - ADHD - Developmental Pilot Study of External Trigeminal Nerve Stimulation for ADHD
    • Monarch eTNS System - Depression
      • Monarch eTNS System - Depression Product Overview
        • Table Monarch eTNS System - Depression - Product Status
        • Table Monarch eTNS System - Depression - Product Description
      • Monarch eTNS System - Depression Clinical Trial
        • Table Monarch eTNS System - Depression - Effect of TNS for Major Depressive Disorder in the Elderly: A Phase II Randomized Controlled Trial
        • Table Monarch eTNS System - Depression - External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Depression
        • Table Monarch eTNS System - Depression - Transcutaneous Vagus Nerve Stimulation for Treating Major Depressive Disorder: A Phase II, Randomized, Double-blind Clinical Trial
    • Monarch eTNS System - Epilepsy
      • Monarch eTNS System - Epilepsy Product Overview
        • Table Monarch eTNS System - Epilepsy - Product Status
        • Table Monarch eTNS System - Epilepsy - Product Description
      • Monarch eTNS System - Epilepsy Clinical Trial
        • Table Monarch eTNS System - Epilepsy - Evaluation of the Monarch eTNS Therapy for Neurological and Neuropsychiatric Disorders in Pediatrics
        • Table Monarch eTNS System - Epilepsy - External Trigeminal Nerve Stimulation for Epilepsy
    • Monarch eTNS System - Lennox-Gastaut Syndrome
      • Monarch eTNS System - Lennox-Gastaut Syndrome Product Overview
        • Table Monarch eTNS System - Lennox-Gastaut Syndrome - Product Status
        • Table Monarch eTNS System - Lennox-Gastaut Syndrome - Product Description
    • Monarch eTNS System - Post-Traumatic Stress Disorder
      • Monarch eTNS System - Post-Traumatic Stress Disorder Product Overview
        • Table Monarch eTNS System - Post-Traumatic Stress Disorder - Product Status
        • Table Monarch eTNS System - Post-Traumatic Stress Disorder - Product Description
    • Monarch eTNS System - Traumatic Brain Injury
      • Monarch eTNS System - Traumatic Brain Injury Product Overview
        • Table Monarch eTNS System - Traumatic Brain Injury - Product Status
        • Table Monarch eTNS System - Traumatic Brain Injury - Product Description
    • sTNS System - Epilepsy
      • sTNS System - Epilepsy Product Overview
        • Table sTNS System - Epilepsy - Product Status
        • Table sTNS System - Epilepsy - Product Description
    • Thin Film Nitinol Flow Diverting Stent
      • Thin Film Nitinol Flow Diverting Stent Product Overview
        • Table Thin Film Nitinol Flow Diverting Stent - Product Status
        • Table Thin Film Nitinol Flow Diverting Stent - Product Description
  • Neurosigma Inc - Key Competitors
  • Neurosigma Inc - Key Employees
    • Table Neurosigma Inc, Key Employees
  • Neurosigma Inc - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
      • Table Neurosigma Inc, Subsidiaries
  • Recent Developments
    • Neurosigma Inc, Recent Developments
      • Oct 30, 2017: UCLA Team Reports Positive Topline Results from Double-Blind Trial of NeuroSigma's Non-Invasive eTNS System for Treatment of Pediatric ADHD
      • Jan 28, 2016: Electric patch holds promise for treating PTSD
      • Dec 10, 2015: Preliminary Results Utilizing NeuroSigma's Monarch eTNS System for the Treatment of Traumatic Brain Injury Presented at the North American Neuromodulation Society Annual Meeting
      • Nov 16, 2015: NeuroSigma's Monarch eTNS System Receives CE Mark Approval for ADHD
      • May 04, 2015: NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting
      • Jan 06, 2015: FDA Grants NeuroSigma Humanitarian Use Device (HUD) Designation
      • Jan 05, 2015: UCLA Launches Phase II Pediatric Clinical Trial for the Treatment of ADHD with NeuroSigma's eTNS System
      • Nov 19, 2014: NeuroSigma Congratulates Brazilian Medical Team for Their Top-Line Results in Phase II Clinical Trial of eTNS for Treatment of Depression
      • Nov 17, 2014: NeuroSigma Announces Top-Line Findings of UCLA Phase II Clinical Trial of eTNS for the Treatment of Depression
      • Nov 03, 2014: NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report